Michal Hawranek
Overview
Explore the profile of Michal Hawranek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pilat P, Szpila G, Stojko M, Nocon J, Smolarczyk J, Zmudka K, et al.
Medicina (Kaunas)
. 2023 Aug;
59(8).
PMID: 37629668
Adipocytes accumulate triacylglycerols as an energy store, thereby causing an increase in the adipose tissue volume. Weight gain can be prevented through damage to the adipocyte structure or an increase...
12.
Siudak Z, Hawranek M, Kleczynski P, Bartus S, Kusa J, Milewski K, et al.
Postepy Kardiol Interwencyjnej
. 2023 Jul;
19(2):82-85.
PMID: 37465633
No abstract available.
13.
Huczek Z, Protasiewicz M, Dabrowski M, Parma R, Hudziak D, Olszowka P, et al.
Kardiol Pol
. 2023 Jun;
81(6):646-668.
PMID: 37319015
Over 15 years of clinical experience and multiple large-scale observational studies followed by guidelines show good safety and efficacy of valve-in-valve transcatheter aortic valve implantation TAVI (ViV-TAVI), which reduces the...
14.
Szczurek-Wasilewicz W, Hawranek M, Skrzypek M, Hrapkowicz T, Gasior M, Warmusz O, et al.
Postepy Kardiol Interwencyjnej
. 2023 Feb;
18(3):237-245.
PMID: 36751283
Introduction: Cardiac allograft vasculopathy (CAV) is a major threat to long-term survival after heart transplantation (HT). Aim: To determine factors associated with CAV detection in patients after HT. Material And...
15.
Kazirod-Wolski K, Sielski J, Gasior M, Bujak K, Hawranek M, Pyka L, et al.
Kardiol Pol
. 2022 Nov;
81(3):265-272.
PMID: 36404732
Background: Intravascular ultrasound (IVUS) and fractional flow reserve (FFR) are invasive procedures increasingly used in treating acute coronary syndrome (ACS). Aims: This study aimed to evaluate the frequency of IVUS...
16.
Siudak Z, Bartus S, Hawranek M, Kusa J, Kleczynski P, Milewski K, et al.
Postepy Kardiol Interwencyjnej
. 2022 Sep;
18(2):87-89.
PMID: 36051825
No abstract available.
17.
Wilczek K, Hawranek M, Wojakowski W, Chodor P, Zembala M, Buszman P, et al.
Anatol J Cardiol
. 2022 Mar;
26(3):172-179.
PMID: 35346903
Background: Data concerning the comparison between transcatheter aortic valve implantation and surgical aortic valve replacement in a real-world setting are scarce and in Central and Eastern Europe no such data...
18.
Januszek R, Siudak Z, Malinowski K, Wanha W, Wojakowski W, Reczuch K, et al.
Catheter Cardiovasc Interv
. 2022 Mar;
99(6):1723-1732.
PMID: 35318789
Background: Low operator and institutional volume are associated with poorer procedural and long-term clinical outcomes in the general population of patients treated with percutaneous coronary interventions (PCI). Aim: To assess...
19.
Hawranek M, Pyka L, Szygula-Jurkiewicz B, Desperak P, Szczurek W, Lekston A, et al.
Postepy Kardiol Interwencyjnej
. 2022 Feb;
17(4):349-355.
PMID: 35126549
Introduction: Cardiac allograft vasculopathy remains one of the most important factors leading to chronic cardiac allograft rejection. When revascularization is needed percutaneous coronary interventions are the method of choice. Aim:...
20.
Dyrbus M, Desperak P, Pawelek M, Mozdzen M, Gasior M, Hawranek M
Cardiol J
. 2021 Dec;
PMID: 34897641
Background: The data on the association between serum uric acid (sUA) concentration and outcomes in patients with an ACS are inconsistent and do not focus on patients with non-ST-segment elevation...